Why Cellular RPM Devices Are the Gold Standard for US RPM Success
Connectivity dictates RPM programme success. Choosing the wrong transport type is one of the most common causes of failure in US vital-sign programmes.
Connectivity dictates the success of Remote Patient Monitoring programmes in the United States. Choosing the wrong connection type is a frequent cause of failure, and it is usually decided early — when hardware is selected.
Bluetooth depends on a phone you do not control
Bluetooth devices are cheaper per unit and fine for engaged, smartphone-literate patients. The problem is the population that needs monitoring most is often not that population. Every extra step — open app, wait for sync, confirm upload — is a place where adherence leaks.
Cellular removes the phone from the loop
A cellular device measures and transmits. From the patient’s point of view the workflow is identical to a device with no connectivity at all. That is the point. For programmes where adherence drives billing eligibility, this is usually worth the higher unit cost.
Choosing between them
- Cellular for chronic programmes with low digital literacy, or where adherence is the binding constraint.
- Bluetooth for app-engaged cohorts, cost-sensitive pilots, or where a hub device is already present.
- Both, in a single supplier catalogue, so the programme can segment rather than compromise.
AOJ Medical ships both transport types from one device platform, so a programme can segment by cohort instead of picking one compromise for everyone.
